EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Advances in breast cancer screening modalities and status of global screening programs

Chenyu Luo iD, Le Wang, Yuhan Zhang, Ming Lu, Bin Lu, Jie Cai, Hongda Chen iD, Min Dai

Chronic Diseases and Translational Medicine · 2022-06 · 8 (2) · 112-123

DOI: 10.1002/cdt3.21 ↗

At a glance

Übersichtsarbeit in Chronic Diseases and Translational Medicine, published online on 2022-05-25. Written by Chenyu Luo and 7 co-authors. Institution: Medical Research Center, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. Cited 26 times so far (Crossref); 89 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Natural Science Foundation of Beijing Municipality.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward trend has been predicted in the coming decades. Screening in selected targeted populations, which is effective in reducing cancer‐related mortality, has been widely implemented in many countries. This review summarizes the advances in BC screening techniques, organized or opportunistic BC screening programs across different countries, and screening modalities recommended by different academic authorities. Mammography is the most widely used and effective technique for BC screening. Other complementary techniques include ultrasound, clinical breast examination, and magnetic resonance imaging. Novel screening tests, including digital breast tomosynthesis and liquid biopsies, are still under development. Globally, the implementation status of BC screening programs is uneven, which is reflected by differences in screening modes, techniques, and population coverage. The recommended optimal screening strategies varied according to the authoritative guidelines. The effectiveness of current screening programs is influenced by several factors, including low detection rate, high false‐positive rate, and unsatisfactory coverage and uptake rates. Exploration of accurate BC risk prediction models and the development of risk‐stratified screening strategies are highly warranted in future research.

Subjects

Author keywords

breast cancerguidelinemammographyscreeningultrasound

Authors and institutions

  • Medical Research Center, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
  • Department of Cancer Prevention Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Hangzhou Zhejiang China.
  • Department of General Surgery, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

ORCID profiles: Chenyu Luo, Hongda Chen

Funding

  • Natural Science Foundation of Beijing Municipality

Cite

APA

Luo, C., Wang, L., Zhang, Y., Lu, M., Lu, B., Cai, J., Chen, H., & Dai, M. (2022). Advances in breast cancer screening modalities and status of global screening programs. Chronic Diseases and Translational Medicine, 8(2), 112-123. https://doi.org/10.1002/cdt3.21

Vancouver

Luo C, Wang L, Zhang Y, Lu M, Lu B, Cai J, et al. Advances in breast cancer screening modalities and status of global screening programs. Chronic Diseases and Translational Medicine. 2022;8(2):112-123. doi:10.1002/cdt3.21

BibTeX
@article{Luo2022,
  author = {Luo, Chenyu and Wang, Le and Zhang, Yuhan and Lu, Ming and Lu, Bin and Cai, Jie and Chen, Hongda and Dai, Min},
  title = {Advances in breast cancer screening modalities and status of global screening programs},
  journal = {Chronic Diseases and Translational Medicine},
  year = {2022},
  volume = {8},
  number = {2},
  pages = {112--123},
  doi = {10.1002/cdt3.21}
}
Start for free →